Jefferies Group LLC Buys 35,291 Shares of Waters Co. (WAT)

Share on StockTwits

Jefferies Group LLC increased its stake in shares of Waters Co. (NYSE:WAT) by 1,121.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 32,143 shares of the medical instruments supplier’s stock after purchasing an additional 35,291 shares during the period. Jefferies Group LLC’s holdings in Waters were worth $6,258,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of WAT. Fundsmith Equity Fund L.P. acquired a new stake in shares of Waters during the second quarter worth $915,485,000. Bank of New York Mellon Corp lifted its holdings in shares of Waters by 156.1% during the second quarter. Bank of New York Mellon Corp now owns 4,358,976 shares of the medical instruments supplier’s stock worth $843,852,000 after purchasing an additional 2,657,055 shares during the period. Schwab Charles Investment Management Inc. lifted its holdings in shares of Waters by 73.7% during the second quarter. Schwab Charles Investment Management Inc. now owns 497,433 shares of the medical instruments supplier’s stock worth $96,299,000 after purchasing an additional 211,068 shares during the period. Wells Fargo & Company MN lifted its holdings in shares of Waters by 40.5% during the second quarter. Wells Fargo & Company MN now owns 336,181 shares of the medical instruments supplier’s stock worth $65,081,000 after purchasing an additional 96,866 shares during the period. Finally, Schroder Investment Management Group lifted its holdings in shares of Waters by 64.8% during the second quarter. Schroder Investment Management Group now owns 208,983 shares of the medical instruments supplier’s stock worth $40,501,000 after purchasing an additional 82,175 shares during the period. 98.51% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $192.00, for a total value of $672,000.00. Following the completion of the transaction, the director now owns 20,911 shares in the company, valued at $4,014,912. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Christopher A. Kuebler sold 8,000 shares of the firm’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $199.67, for a total value of $1,597,360.00. Following the completion of the transaction, the director now owns 18,911 shares of the company’s stock, valued at approximately $3,775,959.37. The disclosure for this sale can be found here. Company insiders own 0.98% of the company’s stock.

A number of equities research analysts have commented on WAT shares. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating in a report on Thursday, August 23rd. Goldman Sachs Group downgraded Waters from a “neutral” rating to a “sell” rating and reduced their target price for the company from $185.00 to $180.00 in a report on Friday, November 30th. ValuEngine raised Waters from a “hold” rating to a “buy” rating in a report on Tuesday, November 27th. UBS Group started coverage on Waters in a report on Tuesday, October 9th. They issued a “neutral” rating and a $210.00 target price for the company. Finally, Cleveland Research raised Waters from a “sell” rating to a “neutral” rating in a report on Thursday, October 11th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. Waters presently has an average rating of “Hold” and an average target price of $205.07.

Waters stock opened at $188.94 on Friday. Waters Co. has a one year low of $167.93 and a one year high of $220.20. The company has a debt-to-equity ratio of 0.61, a current ratio of 6.63 and a quick ratio of 5.93. The firm has a market capitalization of $14.69 billion, a price-to-earnings ratio of 24.33, a price-to-earnings-growth ratio of 2.32 and a beta of 0.97.

Waters (NYSE:WAT) last released its earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.02. Waters had a return on equity of 30.68% and a net margin of 2.32%. The company had revenue of $578.02 million during the quarter, compared to the consensus estimate of $587.43 million. During the same quarter last year, the company earned $1.77 earnings per share. Waters’s quarterly revenue was up 2.2% compared to the same quarter last year. On average, analysts predict that Waters Co. will post 8.05 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4001161/jefferies-group-llc-buys-35291-shares-of-waters-co-wat.html.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Story: Municipal Bonds

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Abeona Therapeutics  Rating Increased to Sell at BidaskClub
Abeona Therapeutics Rating Increased to Sell at BidaskClub
Nokia Oyj  Rating Increased to Hold at ValuEngine
Nokia Oyj Rating Increased to Hold at ValuEngine
ValuEngine Upgrades Toyota Motor  to Hold
ValuEngine Upgrades Toyota Motor to Hold
ValiRx  Stock Price Down 14.3%
ValiRx Stock Price Down 14.3%
Critical Contrast: Viad  and EFactor Group
Critical Contrast: Viad and EFactor Group
Independence  vs. American Equity Investment Life  Head to Head Survey
Independence vs. American Equity Investment Life Head to Head Survey


Leave a Reply

© 2006-2018 Ticker Report